Discordant rifampicin susceptibility results are associated with Xpert(®) MTB/RIF probe B and probe binding delay

nork Berhanu, R. H., Schnippel, K., Kularatne, R., Firnhaber, C., Jacobson, K. R., Horsburgh, C. R., Lippincott, C.K.
Argitaratua izan da Int J Tuberc Lung Dis (2019)

Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay

nork Berhanu, R. H., Schnippel, K., Kularatne, R., Firnhaber, C., Jacobson, K. R., Horsburgh, C. R., Lippincott, C.K.
Argitaratua izan da Int J Tuberc Lung Dis (2019)

Overcoming limitations of tuberculosis information systems: researcher and clinician perspectives

nork van der Heijden, Y. F., Hughes, J., Dowdy, D. W., Streicher, E., Chihota, V., Jacobson, K. R., Warren, R., Theron, G.
Argitaratua izan da Public Health Action (2019)

The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis

nork Ragan, E. J., Kleinman, M. B., Sweigart, B., Gnatienko, N., Parry, C. D., Horsburgh, C. R., LaValley, M. P., Myers, B., Jacobson, K. R.
Argitaratua izan da Int J Tuberc Lung Dis (2020)

Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa

nork Mukinda, F. K., Theron, D., van der Spuy, G. D., Jacobson, K. R., Roscher, M., Streicher, E. M., Musekiwa, A., Coetzee, G. J., Victor, T. C., Marais, B. J., Nachega, J. B., Warren, R. M., Schaaf, H. S.
Argitaratua 2012